Icure Pharmaceutical Incorporation (KOSDAQ:175250)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Cosmetics Division	26.43B	16.42B	12.96B	13.70B	31.19B
Cosmetics Division Growth	61.00%	26.73%	-5.47%	-56.06%	-26.05%
Pharmaceutical Business Division	42.77B	40.39B	46.41B	50.58B	58.96B
Pharmaceutical Business Division Growth	5.91%	-12.98%	-8.24%	-14.21%	214.50%
Total	69.21B	56.81B	59.37B	64.28B	90.14B
Total Growth	21.83%	-4.31%	-7.65%	-28.69%	47.97%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Export	1.97B	520.11M	1.03B	4.54B	5.96B
Export Growth	279.62%	-49.61%	-77.26%	-23.90%	268.27%
South Korea	67.23B	56.29B	58.33B	59.74B	84.18B
South Korea Growth	19.45%	-3.51%	-2.36%	-29.03%	41.95%
Total	69.21B	56.81B	59.37B	64.28B	90.14B
Total Growth	21.83%	-4.31%	-7.65%	-28.69%	47.97%

Source: S&P Global Market Intelligence.